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Vibrio harveyi has been reported as the dominant heterotrophic bacterial species in western 32 
Mediterranean coastal areas during warm seasons, and is recognized as an economically 33 
significant pathogen for the aquaculture industry. The present work aimed to evaluate the 34 
pathogenicity of a V. harveyi strain isolated from ascitic fluid collected from cultured gilthead 35 
seabream and then used in a challenge experiment involving the two most important fish 36 
species in Mediterranean aquaculture: gilthead seabream, Sparus aurata and European seabass, 37 
Dicentrarchus labrax. The ascitic fluid from diseased juvenile seabreams, previously vaccinated 38 
against Photobacterium damselae and Vibrio anguillarum, was extracted and bacteria cultivated 39 
for isolation and characterization. Additionally, different tissues were sampled for histological 40 
evaluation and description. Significant histopathological responses were observed in hepatic 41 
and mucosal tissues. One of the strains isolated from ascitic fluid, IRTA 17-43, was selected for 42 
a bacterial challenge. Additionally, the attenuation of virulence through sequential passage of 43 
the strain on solid media was also assessed. In parallel, a co-habitation trial was performed in 44 
order to evaluate the possible transfer of the bacteria between injected and healthy individuals. 45 
Pathogenicity trials in gilthead seabream resulted in only 25% mortality when injected with 107 46 
CFU mL−1, whereas, for European seabass, a mortality of 95% was recorded, with clear signs of 47 
vibriosis. When passed sequentially on solid media, the strain IRTA-17-43 showed a decrease of 48 
35% in cumulative mortality for European seabass. No apparent transmission of the pathogen 49 
occurred during the co-habitation trial for both species. In conclusion, although few external 50 
signs of V. harveyi are observed in vaccinated carriers, internal effects of the infection were clear 51 
and severe. Although no horizontal transfer of infection was observed, the risk of occurrence 52 
between carriers and immunosuppressed individuals or between different species should be 53 
considered. This further validates that the establishment of a good health management system 54 
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1. Introduction   62 
Vibrio spp. are ubiquitous in the marine environment, particularly in tropical and temperate 63 
waters, representing the major bacterial pathogens affecting development of fish farming 64 
(Austin and Austin, 2012; Vandenberghe et al., 2003; Zorrilla et al., 2003a), especially in the 65 
Mediterranean Sea (Pujalte et al., 2003a). One of the most commonly isolated marine Vibrio 66 
species, Vibrio harveyi [syn. V. carchariae] (Gauger and Gómez-Chiarri, 2002) is a marine Gram-67 
negative bioluminescent bacteria with a requirement for sodium chloride (Farmer et al., 2005). 68 
The species has been described as free-living, associated to some microalgae blooms, or 69 
associated to the intestinal microbiota (Makemson and Hermosa, 1999; Miller et al., 2005; 70 
Ramesh et al., 1990). V. harveyi  has also been reported during warm seasons, as the dominant 71 
heterotrophic bacterial species in western Mediterranean coastal areas (Arias et al., 1999; 72 
Ortigosa et al., 1994; Pujalte et al., 1999) and elsewhere, that can be present in expansive 73 
blooms (e.g. 15,400 km2 of sea surface) in association with species of microalgae (Miller et al., 74 
2005). Moreover, it is recognized as an economically significant pathogen for the aquaculture 75 
industry (Cano-Gomez et al., 2009), with some sporadic cases of wound infections in humans 76 
also reported (Austin, 2010; Del Gigia-Aguirre et al., 2017).  77 
As a serious pathogen affecting the aquaculture industry V. harveyi has effected many marine 78 
vertebrate and invertebrates (Austin and Zhang, 2006), and is frequently isolated from marine 79 
bivalves with implications in some mass mortalities of shellfish (Pass et al., 1987; Sawabe et al., 80 
2007; Travers et al., 2008). Additionally, some studies have described V. harveyi as pathogenic 81 
for several species of crustacean larvae (Diggles et al., 2000; Karunasagar et al., 1994; Lavilla-82 
Pitogo et al., 1990; Liu et al., 1996; Robertson et al., 1998; Vandenberghe et al., 1999). Moreover, 83 
it has also been associated to several opportunistic infections in fish, and responsible for several 84 
cases of infectious necrotizing enteritis, which is characterized by redness of the anal area, 85 
abdominal swelling with accumulation of ascitic fluid, inflammation of the anterior intestine and 86 
necrosis of the posterior intestine (Austin and Zhang, 2006). Several cultured fish species with 87 
economic relevance are globally affected, such as rainbow trout (Oncorhynchus mykiss), Atlantic 88 
salmon (Salmo salar L.) (Zhang and Austin, 2000), Senegalese sole (Solea senegalensis) (Zorrilla 89 
et al., 2003a), Japanese seabass (Lateolabrax japonicus) (Lee et al., 2002), cobia (Rachycentron 90 
canadum) (Liu et al., 2004b), common dentex (Dentex dentex) (Company et al., 1999; Pujalte et 91 
al., 2003b), among others.  92 
Gilthead seabream, Sparus aurata and European seabass, Dicentrarchus labrax are presently the 93 
dominant fish species cultured along the Mediterranean coast (FAO, 2005-2018). Infections and 94 
mortality episodes observed in cultured seabream and seabass seem to be the result of the 95 
interaction of several factors such as poor water quality, seasonality, age-related host 96 
susceptibility, stress and pathogen virulence (Abdel-Aziz et al., 2013; Austin and Austin, 2012). 97 
Moreover, both fish species are often cultivated at the same farms or in very close proximity. 98 
Therefore, it is very relevant to assess the level of risk posed by pathogens, which are sharing 99 
tank facilities or where both fish species coexist in the same water masses.  100 
Several bacterial species have been described as common pathogens in cultured gilthead 101 
seabream (Balebona et al., 1998; Rodgers and Furones, 1998; Toranzo et al., 2005). The genus 102 
Vibrio includes opportunistic pathogens that can affect cultured gilthead seabream (Balebona 103 
et al., 1998; Haldar et al., 2010) and European seabass (Pujalte et al., 2003b). Pujalte et al. 104 
(2003a) reported V. harveyi as the most frequent species recovered from diseased and 105 
asymptomatic gilthead seabream cultured in the Spanish Mediterranean area, from larval to 106 
commercial sizes. Disease outbreaks due to V. harveyi exhibit clear seasonal variation with 107 
increased prevalence coinciding with temperatures above 20 °C (Arias et al., 1999; Pujalte et al., 108 
1999) and it was also suggested that its increased prevalence could lead to co-infection of other 109 
bacterial pathogens (Pujalte et al., 2003a). Furthermore, in a recent study, Scarano et al. (2014) 110 
demonstrated that gilthead seabream reared in sea cages are a potential source of Vibrio spp. 111 
exhibiting resistance against the most commonly used antibiotics. Recently, in a survey assessing 112 
the main pathogens threatening aquaculture in the Mediterranean (Vendramin et al., 2016), V. 113 
harveyi was recognized as an emerging problem in seabass. 114 
Although bacterial infections in fish farming systems are common, the present study was 115 
designed to determine and compare differences in susceptibilities of  the two most important 116 
fish species in the Mediterranean aquaculture, Gilthead seabream (S. aurata) and European 117 
seabass (D. labrax), to a strain of Vibrio harveyi isolated from cultured seabream during a 118 
separate previous nutritional trial. This study aimed to assess the risk and the vulnerability of 119 
these two species to this strain of V. harveyi encountered in a naturally occurring epizootic 120 
event. Additionally, an attempt to attenuate virulence using serial passage on laboratory media 121 




2. Materials and methods 126 
2.1. Fish rearing conditions 127 
During October and November of 2017, over the course of a nutritional assay at IRTA facilities 128 
(Sant Carles de la Ràpita), located in the western Mediterranean (Tarragona, Spain), some 129 
isolated cases of abdominal swelling with an accumulation of ascitic fluid were observed in 130 
cultured juveniles of gilthead seabream (mean ± SD; 15.0 ± 0.5 cm length; mean body weight 131 
81.3 ± 3.8 g), with a cumulative mortality of 3%. Initially, fish were stocked in 200 L tanks at a 132 
density of 2 kg m-3 under environmental conditions of ambient photoperiod and water 133 
temperature (18–22 °C). Prior to their transport to IRTA, fish were routinely vaccinated at the 134 
hatchery against Photobacterium damselae and Vibrio anguillarum. Three months after arrival, 135 
four diseased fish, showing clear signs of ascites and erratic swimming behavior, were collected 136 
to determine the etiology of the problem. Necropsy showed clear pathological signs of infection 137 
with severe inflammation of the digestive tract, predominantly in the posterior intestine and 138 
anus.  139 
 140 
2.2. Pathogen detection and identification 141 
For the bacteriological analysis, ascitic fluid was extracted aseptically with a syringe and plated 142 
onto Thiosulfate-citrate-bile salts-sucrose agar (TCBS) media and Trypticase Soy Agar (TSA) 143 
supplemented with 2.5% NaCl (TSA 3% final concentration). Plates were incubated at 23 ± 1 °C 144 
for 48-72 h. After recovery of what appeared to be a pure bacterial culture on TCBS plates from 145 
ascitic fluid samples, colonies from plates, each corresponding to individual fish, were cultivated 146 
on TSA 3% at 23 °C for 48-72 h for purification and further characterization. Pure cultures of 147 
these isolates were characterized by Gram-staining and DNA sequencing (see below), then 148 
stored at −80 °C in glycerol (80%) until further use. Samples from liver, spleen, digestive tract 149 
and gills were also collected and stored in buffered formalin 10% for histological analysis (see 150 
below).    151 
 152 
2.3. Molecular characterization 153 
For identification of the bacterial isolates, DNA from pure cultures of four isolates from 154 
seabream (one strain per fish) were extracted using DNeasy® Blood & Tissue Kit (Qiagen) 155 
following manufacturer´s protocol. The DNA concentration and purity was quantified using a 156 
Nano-drop 2000 (Thermo Scientific). PCR amplifications were performed using the 16S-specific 157 
primers Eub A and Eub B (Suzuki and Giovannoni, 1996) that amplify a region of 1600 bp of the 158 
16S rRNA. Using these primers, amplification was performed in 20 μL reactions containing Taq 159 
polymerase buffer (1×), 0.5 U of Taq polymerase, MgCl2 (2 mM), dNTP's (900 μM), and 1 μM of 160 
each primer. The amplification conditions included 5 min at 95 °C followed by 30 s at 94 °C, 45 s 161 
at 48 °C, and 1.5 min at 72 °C for 35 cycles, and terminating with a final extension cycle of 7 min 162 
at 72 °C. PCR products were separated on a 1.2% (w/v) agarose gel and visualized using ethidium 163 
bromide staining. Positive results were compared to a molecular weight standard (1Kb Plus DNA 164 
Ladder, Invitrogen) to assess molecular weight, then prior to sequence analysis, amplified DNA 165 
was purified using standard spin-column protocols described for the PCR Purification Kit (Ref# 166 
28104, Qiagen, Spain). Sequencing was performed by Sistemas Genómicos (Valencia, Spain). 167 
Tentative identity was established by a BLAST comparison of the sequence obtained to the 16S 168 
rDNA data set in GenBank. Phylogenetic analysis was performed with 21 taxa and a total of 571 169 
nucleotide positions in the final data set using Maximum Likelihood and Neighbor-Joining 170 
methods in MEGA X. In selecting taxa from GenBank for these analyses, sequences shorter than 171 
600 bp, or sequences with numerous inconclusively determined nucleotides were excluded, 172 
whereas all positions containing gaps and missing data were eliminated. The evolutionary 173 
history was inferred by using the Maximum Likelihood method based on the Kimura 2-174 
parameter model. A discrete Gamma distribution was used to model evolutionary rate 175 
differences among sites [5 categories (+G, parameter = 0.3906)].  176 
For confirmation of the etiological agent,  screening of both the infected fish, from the challenge 177 
experiments (see below) and from the original stock of diseased seabream (n=10), was done 178 
using V. harveyi specific primers (Pang et al., 2006). Amplification was performed in 20 μL 179 
reactions containing Taq polymerase buffer (1×), 0.5 U of Taq polymerase, MgCl2 (2 mM), dNTP's 180 
(900 μM), and 1 μM of each primer specific for V. harveyi. The conditions for amplification were 181 
as follows: Initial denaturation of template DNA at 95 °C for 10 min, followed by 30 cycles of 1 182 
min at 92 °C, 1 min at 55 °C, and 1 min at 72 °C with a final extension step of 7 min at 72 °C. The 183 
presence of bands with a size of 382 bp were considered as a positive result. Reactions lacking 184 
DNA, and containing genomic DNA of V. harveyi, were used as negative and positive controls, 185 
respectively. Visualization of PCR products was performed as described above. 186 
  187 
2.4. Histology 188 
Moribund fish used for bacteria identification were also dissected and biopsies of different 189 
tissues (liver, gall bladder, posterior intestine, spleen and gills) were taken for the histological 190 
description of the impact of the pathogenic bacteria on the above-mentioned tissues. For this 191 
purpose, tissue samples were fixed in 10% buffered formalin (Scharlab S.L, Spain) then 192 
dehydrated in a graded series of ethanol (Scharlab S.L, Spain) (70–96%), embedded in paraffin 193 
blocks and cut into serial sagittal sections (2–3 μm) with a microtome (Leica RM2155, Germany). 194 
Sections were stained using Harris' haematoxylin and eosin. Photo-microscopy was performed 195 
and images analysed with a Leitz-Diaplan microscope (Wetzlar, Germany) coupled with a Spot 196 
Insight Color camera (x4, x10, x20). 197 
 198 
2.5. Biosecurity rearing conditions 199 
In order to test the potential virulence of the V. harveyi strain recovered from animals with 200 
abdominal swelling and an accumulation of ascitic fluid, a challenge test was designed. For this 201 
purpose, unvaccinated gilthead seabream and European seabass were obtained from a 202 
commercial hatchery located in the western Mediterranean and transported to IRTA facilities. 203 
Before the challenge, fish were stocked under quarantine conditions for 3 weeks and subjected 204 
to bacteriological analysis in order to validate their health status. Briefly, a random sample of 10 205 
fish were screened to assess the absence of potential pathogens. Fish were euthanized with an 206 
overdose of MS-222, their head kidneys were sampled under aseptic conditions and individual 207 
samples swabbed onto TSA-NaCl and TCBS plates (incubated at 23 ± 1°C for 48-72 h). None of 208 
the TSA-NaCl and TCBS plates inoculated with seabass samples showed significant bacterial 209 
growth. There were a few isolated colonies that grew on TCBS and TSA-NaCl plates in 1/10 210 
gilthead seabream; these were tested for V. harveyi using specific PCR, but results were 211 
negative. 212 
The bacterial challenge experiments were performed at IRTA’s biosecurity room under level 2 213 
biocontainment conditions  in 32 cylindrical  tanks (100 L), provided with water recirculation 214 
using an IRTAmar® RAS system (5-10 % renewal flow/day), including mechanical filtration and 215 
biofiltration, ultraviolet water treatment and chlorination, as well as ozone treatment of the 216 
outflow water. Stocking conditions were fixed at 32‰ of salinity at 21 ± 1 °C.  The IRTAmar® RAS 217 
is controlled by Zenaqua® software. 218 
 219 
Seven-hundred seabream (7.0 ± 2.2 g) were randomly and equally distributed 220 
(www.randomizer.org) into fourteen tanks, with 50 fish per tank. For the seabass assay, four-221 
hundred-twenty fish (46.0 ± 8.8 g) were randomly distributed into fourteen tanks with 30 fish 222 
per tank. Six experimental challenge conditions and a control group injected with PBS were 223 
established. Each experimental condition was tested in duplicate tanks. During the acclimation 224 
period, fish were fed ad-libitum with a commercial diet (50% crude protein, 15% crude fat; MAR-225 
PERLA MP-T, Skretting). 226 
 227 
2.6. Pathogenicity assay and co-habitation trial 228 
Based on results of a preliminary pathogenicity assay performed on juvenile (15 g) European  229 
seabass comparing all the isolates collected during the afore-mentioned nutritional assay (data 230 
not shown), one strain of V. harveyi isolated from seabream (reference# IRTA-17-43) was 231 
selected for the virulence studies. Bacterial suspensions were prepared from inoculum grown 232 
on TSA-NaCl plates using the stock strains stored in glycerol at -80 °C. Cell suspensions were 233 
prepared to an O.D. λ = 550nm  of 0.6, this being the density previously established by serial dilutions 234 
and plate counting as 108 colony forming units (CFU) mL−1.  This suspension was serially diluted 235 
ten-fold under sterile conditions, using sterile phosphate buffered saline (PBS), to prepare each 236 
dosage of bacterial inoculum to be used for the challenge by intraperitoneal injection. Prior to 237 
injection, fish were anaesthetized by immersion in tricaine methanesulfonate (MS-222, Sigma), 238 
then each fish was injected with 0.1 mL of bacterial suspension, comprising 104, 105, 106 or 107 239 
CFU mL−1 (50 fish per dose per tank in the case of seabream and 30 fish per dose per tank for 240 
seabass). In parallel, a co-habitation trial was performed in order to assess the possible transfer 241 
of the pathogenic bacteria between injected (107 CFU mL−1) and healthy individuals within the 242 
same tank (1:1). Injected and non-injected fish were distinguished by caudal fin clipping of the 243 
non-injected fish. Furthermore, a last experimental group was injected with 107 CFU mL−1 of the 244 
same strain after it had been submitted to successive passages on solid media (×7), to attenuate 245 
virulence through sequential passage outside the host. Two control groups were included: one 246 
intraperitoneally injected with PBS, and another control group for caudal fin clipping. Sampling 247 
of co-habitation individuals were performed before inoculation of co-habitant siblings (T = 0) 248 
and at 4, 24, 72 and 96 hours post-inoculation. Fish were fasted one day prior to inoculation and 249 
fed a commercial diet twice a day during the course of the experiment as already described.  250 
Fish mortalities occurring after 12 h post-inoculation were considered to be induced by the 251 
pathogen injection, rather than handling stress, since no casualties were found in the control 252 
group. Mortality was recorded up to 15 days post-injection, with supervision of animals’ 253 
condition every two hours, six times a day. When moribund animals were observed they were 254 
sacrificed with an overdose of MS-222 in order to avoid unnecessary suffering. At the end of the 255 
assay, all the remaining fish were sacrificed similarly. Confirmation of cause of death was 256 
determined by the recovery of the bacteria from head kidney samples cultured on TCBS and 257 
TSA-NaCl, and by specific PCR using DNA obtained from those bacterial colonies, as described 258 
above. Head kidney samples from survivors and asymptomatic fish were also plated on TCBS 259 
and TSA-NaCl media to check for pathogen presence and/or prevalence, and to evaluate the 260 
establishment of carrier-status of fish. Determination of the Lethal Dose 50% (LD50) was 261 
conducted by means of Probit analysis using the IBM SPSS Statistics 20.0 software.  262 
All animal experimental procedures were conducted in according to the experimental research 263 
protocol approved by the Committee of Ethics and Animal Experimentation of the Institut de 264 
Recerca i Tecnologia Agroalimentàries and in agreement with the Guidelines of the European 265 
Union Council (86/609/EU) for the use of laboratory animals. 266 
 267 
3. Results 268 
3.1. Pathogen characterization and identification  269 
All bacterial isolates from ascitic fluid of diseased gilthead seabream were Gram negative rods 270 
(~1.5 µm x 0.8 µm). On TSA-NaCl plates, colonies were pale cream-colored with a raised center 271 
and peripheral swarm rings. On TCBS agar media, the colonies appeared yellow with crenellated 272 
edges. The 16S rDNA sequences were compared to the online database GenBank using the 273 
BLAST utility and multiple V. harveyi strains were identified as having identical sequences. From 274 
this result, the species was presumptively identified as Vibrio harveyi (Fig. 1). The confirmation 275 
of this was performed using species-specific PCR, which confirmed the isolates obtained as V. 276 
harveyi. From this point on, the strain IRTA 17-43 was designated as the challenge strain and use 277 
as a positive control for further screening of fish collected during the bacterial challenge trials 278 
(Fig. 2). 279 
After the challenge, head kidney samples from recently dead or moribund individuals of both 280 
fish species were inoculated on TCBS media producing distinct bacterial colonies when 281 
recovered from each fish host species. Colonies from gilthead seabream appeared greyish-282 
green, whereas those recovered from European seabass were opaque yellow with clear sucrose 283 
degradation of the media. 284 
 285 
Figure 1. Phylogenetic relationship among IRTA 17-43 strain 16S rDNA sequence and others from 286 
the Vibrio genus. The scale for branch length (0.01 substitutions/site) is shown below the tree. 287 
The evolutionary history was inferred by using the Maximum Likelihood method based on the 288 
Kimura 2-parameter model. The tree with the highest log likelihood (-1124.5729) is shown. The 289 




Figure 2. Examples of specific PCR (Pang et al., 2006) of bacterial colonies recovered from smears 294 
of head kidney from moribund fish. MW= molecular weight standard; Lanes 1-4 are samples 295 
recovered from moribund fish; C-= negative control lacking template DNA; C+= positive control 296 
genomic DNA from strain IRTA 17-43.  297 
 298 
 299 
3.2. Histological analysis in gilthead seabream tissues 300 
The symptomatic juveniles of the diseased seabream showed a remarkable, generalized and 301 
severe congestion in the hepatic and branchial vascular systems (i.e, veins, arteries, sinusoids, 302 
capillaries, bile ducts). About 50% of the fish presented abdominal swelling, with accumulation 303 
of ascitic fluid, while congestion was less evident in the spleen and intestinal mucosa. In the 304 
hepatic parenchyma, numerous inclusions of haemosiderin, biliary pigments (i.e., lipofuscin, 305 
melanin, and haemosiderin pigments) and melanomacrophages were observed. In the 306 
hepatocytes, nuclear pyknosis and karyolysis, compatible with the development of necrotic 307 
processes, were observed (Fig. 3). 308 
Extravasations of blood (i.e, rupture of the wall of the capillaries), epithelial desquamations and 309 
aneurysms at the base of the gill epithelia were observed in diseased fish (Fig. 4a-d). 310 
The gallbladder showed a remarkable enlargement and a strong hypertrophy of the muscle 311 
layer. As in the liver, the spleen also contained a large proportion of haemosiderin deposits, 312 
biliary pigments and melanomacrophages (Fig. 4e). 313 
In the posterior intestine, a severe dilation of the intestinal- villi was observed, due to an 314 
accumulation of inflammatory exudates, separating the mucosal and sub-mucosal layers. In the 315 
intestinal mucosa of the diseased fish, there were signs of nuclear pyknosis, as well as a nuclear 316 
depolarization of the absorptive cells or enterocytes, accompanied by a reduction in the number 317 
of goblet cells (Fig. 4f- h). 318 
 319 
Figure 3.  Liver from S. aurata specimens (a to d correspond to fish 1 and e and f correspond to 320 
fish 2) infected with Vibrio harveyi showing congested blood vessels as well as hemosiderin 321 
deposits (black precipitate) surrounding vasculature (a and b). Note accumulation of bile 322 
pigment (yellow to light-brown deposits) within hepatic cytoplasm (c) and severe shrinkage of 323 
hepatocyte cytoplasm with nuclear pyknosis and hepatocyte necrosis (d). Note also severely 324 

















presence of hemosiderin deposits with vascular congestion by blood cells (e) as well as karyolisis 326 
of the nucleus of hepatocytes and cellular necrosis (f). Scale bars represent 50 µm. bv: blood 327 
vessel; h: hepatocyte; s: sinusoid. 328 
 329 
 
Figure 4.  Gills from S. aurata specimens (a and b from fish 1 and c and d from fish 2) infected 330 
with Vibrio harveyi  showing congested capillaries as well as blood extravasation (arrows) (a) and 331 
epithelial desquamation of epithelium from gill filament (arrowheads) (b). Gills from specimen 332 
2 showing aneurisms in the distal part of secondary lamellae (asterisk) (c) blood extravasation 333 
(arrow) as well as epithelial desquamation (arrowheads) (d). The spleen presented numerous 334 
melanomacrophage centers within splenic parenchyma (arrowheads) (e) whereas the intestine 335 
presented a severe dilation of the intestinal villi (f) and (g), with noticeable presence of 336 
inflammatory exudates filling the lamina propria-submucosa space. Note also, distinctive 337 
nuclear pyknosis related with necrosis, as well as depolarization of the nucleus of the 338 
enterocytes. Scale bars represent 50 µm. 339 
 340 
3.3. Pathogenicity trials in gilthead seabream and European seabass 341 
Results of pathogenicity trials are shown in Figure 5. Mortality was moderate (25%) in seabream 342 
injected with the highest dose of the bacteria (107 CFU mL−1); whereas for European seabass, a 343 
mortality of 95% was recorded in fish injected with the same inoculum dosage. Figure 6 showed 344 
a LD50 of approximately 106 CFU mL−1 established for seabass, and predicted at 109 CFU mL-1 for 345 
seabream. The majority of mortalities occurred within the first 48h after inoculation. No 346 
mortality or clinical signs of bacterial infection were observed when fish were injected with the 347 
lower dose (104 CFU mL−1). After the fourth day post-inoculation until the end of the experiment, 348 
there were no more mortalities for either species. 349 
In contrast to gilthead seabream that showed no clinical signs of infection, dead and moribund 350 
European seabass showed clear signs of vibriosis, such as external hemorrhages in the mouth, 351 
operculum and fins, and inflammation of the vent. For both species, moribund or dead fish that 352 
had been injected were confirmed to be positive for V. harveyi by plate cultivation and species-353 
specific PCR.  354 
The attenuated strain IRTA-17-43 (passed sequentially on solid media), showed a decrease of 355 
35% in cumulative mortality for European seabass, whereas no differences in mortality were 356 
observed in the case of seabream (25%).    357 
During the co-habitation trial no apparent transmission of the pathogen between i.p. injected 358 
and healthy fish occurred, for both seabream and seabass. Non-infected fish did not die, 359 
presented no clinical signs, nor were positive for V. harveyi from head kidney necropsy samples. 360 
At the end of the experiment, all individuals from both fish species that survived their respective 361 
challenge were negative for V. harveyi.  362 
 363 
Figure 5. Accumulated mortality graph in percentage (%) represented by mean values ± standard 364 
error, for gilthead seabream and European seabass intraperitoneally injected with 104, 105, 106 365 
and 107 CFU mL−1 of the V. harveyi strain IRTA-17-43 during the 15 days pathogenicity assay 366 
period. “β” represents fish injected with the strain after successive passages on solid media (×7). 367 
Mortality of the injected fish from the co-habitation trial is represented by “10E7 + ¥”, where 368 
“¥” refers to non-injected individuals (fish with caudal fin clipping). Fish intraperitoneally 369 
injected with PBS (control IP) and fish with caudal fin clipping control group (control ¥) are both 370 
represented and presented a 1% and 0% of accumulated mortality for seabream and seabass, 371 
respectively. Log-rank test for comparisons of Kaplan-Meier mortality curves was applied and 372 
different letters represent significant differences in mortality (p < 0.001). 373 
  374 
375 
Figure 6. Log-Probit mortality graph for the gilthead seabream (A) and European seabass (B) 376 
intraperitoneally injected with 104, 105, 106 and 107 CFU mL−1 of the bacterial strain IRTA-17-43 377 
of V. harveyi. 378 
 379 
4. Discussion 380 
Many of the mortalities described in seabreams cultured in the Mediterranean and Atlantic 381 
areas have been associated with epizootic events related to vibriosis, including etiology by V. 382 
harveyi. In general, this disease in intensive culture systems is characterized by systemic 383 
haemorrhagic septicemia with marked abdominal swelling. Internally, congested blood vessels, 384 
branchial, hepatic and intestinal hemorrhages and ascites are the most common 385 
histopathological signs of this bacterial disease in several species of cultured fish (Borrego et al., 386 
2017). 387 
A V. harveyi strain was recovered from ascitic fluid of several juvenile gilthead seabream (ca. 80 388 
g), presenting abdominal swelling, which then was tested for virulence using intraperitoneal 389 
injection in the two most important farmed Mediterranean marine species, gilthead seabream 390 
and European seabass. This is not the first description of abdominal swelling in seabream larvae 391 
caused by V. harveyi and other Vibrio species (Sedano et al., 1996; Zorrilla et al., 2003b). There 392 
is no former description of these signs in seabream juveniles. However, signs of both ascites and 393 
gastroenteritis were also observed in cultivated juvenile cobia (Rachycentron canadum) infected 394 
with V. harveyi (Liu et al., 2004a) and V. alginolyticus (Liu et al., 2004b). In addition to abdominal 395 
swelling, important histopathological alterations were observed in fish infected with V. harveyi. 396 
Indeed, in symptomatic seabream specimens, characteristic histopathological responses of this  397 
vibriosis  are observed, such as: abdominal swelling, with accumulation of viscous yellowish-398 
bloody fluids in the intestine and gall-bladder, or ascites in the body cavity, and severe and 399 
generalized congestion in a majority of the hepatic and branchial vascular systems (i.e,  400 
capillaries,  sinusoids, bile ducts, etc.). The current results are similar to previous findings in 401 
many other fish species, such as seabass, among others (El-Sharaby et al., 2017; Korun and 402 
Timur, 2008; Liu et al., 2004a; Sedano et al., 1996; Zorrilla et al., 2003b).  It has been reported 403 
that the gastrointestinal tract is involved in the development of this epizootic disease, as a site 404 
of bacterial colonization and multiplication (Sedano et al., 1996).  Haemosiderin deposits appear 405 
to be related to severe haemorrhage, leading to a release of hemoglobin, biliary derived 406 
pigments, etc., which can trigger defense mechanisms such as an increase in multifocal melano-407 
macrophage centers in the spleen, liver, and kidney (Korun and Timur, 2008). These last authors 408 
indicated the presence of generalized haemorrhages in all organs and tissues, including the 409 
lateral musculature, with inflammatory infiltrations, and liquefactive necrosis in the renal 410 
tubules and hematopoietic tissue, leading to signs of anemia in fish infected with V. harveyi and 411 
other species of Vibrio. (El-Sharaby et al., 2017; Korun and Timur, 2008). Besides fish with 412 
obvious abdominal swelling, seabream presenting more mild signs seemed to be adapted to 413 
their condition with no additional pathological signs. It is important to note that while carrier 414 
fish appear to survive the infection, fish that reach market size displaying the more characteristic 415 
signs are not suitable for sale, which can contribute to considerable economical losses.  416 
In our study, an apparently pure culture was obtained directly from the ascitic fluid of gilthead 417 
seabream, which suggests the signs of infection observed were due to a single aetiology. Our 418 
results contrasted with previous studies with gilthead seabream, where V. harveyi was usually 419 
recovered from diseased fish along with other specimens (Pujalte et al., 2003a; Pujalte et al., 420 
2003b; Ramesh et al., 1990). The characterization of bacterial strain IRTA-17-43 was consistent 421 
with the current literature (Austin and Austin, 2012), exhibiting swarming motility on TSA 422 
medium, a behavior observed in other studies on V. harveyi (Lilley and Bassler, 2000; Pujalte et 423 
al., 2003b; Torky et al., 2016). Colony morphology and color are among the various key features 424 
that are usually unique to a particular genus of bacteria, serving as important criteria for 425 
bacterial preliminary identification. However, differences in colony color were observed on TCBS 426 
plates between bacteria recovered from gilthead seabream and European seabass after the 427 
challenge. In a study performed by Musa et al. (2008) with V. harveyi Isolated from black tiger 428 
shrimp (Penaeus monodon), both green and yellow colored colonies were observed in TCBS for 429 
different V. harveyi isolates, suggesting that isolates that exhibited yellow color on TCBS may be 430 
lacking the gene csc B that enable isolates to utilize sucrose. The fact that some Vibrio species 431 
like V. harveyi are variable in the utilization of sucrose from TCBS agar (Harris et al., 1996) might 432 
explain the color variance of bacteria recovered in this study from each fish species. Since only 433 
one purified strain was injected in both gilthead seabream and European seabass, it is 434 
interesting to find after the pathogenicity trial results a dissimilar phenotype is observed. The 435 
relevance of mutation and recombination for evolution of pathogens at both intra- and inter-436 
host levels was recently reviewed in Arenas et al. (2018). The mechanisms described would 437 
enable genetic variants of a pathogen to adapt to fast changing environments, escape the host 438 
immune system and might lead to resistance to chemotherapeutics. At a population level, such 439 
phenomena may produce the genetic diversity needed to initiate epidemics (Arenas et al., 440 
2018). The mechanisms that drove the above-mentioned changes in colony shape and color due 441 
to their passage through two different fish species remain unexplained and deserve further 442 
investigation.  443 
Additionally, V. harveyi strain IRTA-17-43 became attenuated after sequential passage on 444 
synthetic media (35% decrease in mortality in European seabass). Researchers conducting serial-445 
transfer experiments have attributed the continual loss of pathogen virulence in the laboratory 446 
to Muller’s ratchet mechanism (Bergstrom et al., 1999). Muller’s ratchet model states that any 447 
clonally reproducing lineage, from viral or bacterial pathogen, will tend to accumulate 448 
deleterious mutations over time leading to the decrease of the mean fitness of the pathogen 449 
population as compared to the original population (Haigh, 1978). Our study supports a careful 450 
approach towards the use of bacterial strains from collections in experimental pathogenicity 451 
challenges, since prior frequent manipulation in the laboratory of origin may lead to false 452 
negative or inconclusive results.  453 
The present study was in agreement with the previous results from Pujalte et al. (2003b), which 454 
reported pathogenicity for the first time for several strains of V. harveyi in European seabass. In 455 
fact, typical signs of classical septicemia induced by Vibrios (Toranzo et al., 2005) were also 456 
observed for injected European seabass in our study. Pujalte et al. (2003b) also described the 457 
low degree, or total absence, of virulence of some strains of V. harveyi for gilthead seabream, 458 
as we confirmed in our assays which showed lower mortalities obtained for seabream when 459 
compared with those of seabass. However, those results contrasted with those from Balebona 460 
et al. (1998) that reported a LD50 of 105 CFU g-1 body weight for five V. harveyi strains assayed 461 
with gilthead seabream of 5–10 g. This disagreement between different studies demonstrates 462 
that, rather than V. harveyi being considered as a primary pathogen, this species acts as an 463 
opportunistic pathogen and/or its pathogenicity might be restricted in some strains (Pujalte et 464 
al., 2003a; Pujalte et al., 2003b). Although the virulence of the strain IRTA-17-43 was 465 
demonstrated, the original clinical signs of abdominal swelling were not reproduced. The 466 
observed abdominal swelling in this study was consistent with previous studies by Sedano et al. 467 
(1996) with gilthead seabream larvae orally inoculated using Vibrio strains, where it was 468 
suggested that abdominal swelling could be a consequence of the host immune response, or 469 
dependent on the route or dosage of infection. This lack of reproducibility of this specific 470 
pathogenic sign after bacterial challenge in our study may be either due to this latter effect since 471 
the intraperitoneal  injection was not the same route of exposure as occurred originally,  or  due 472 
to the fact that a longer infection time may be needed to reproduce abdominal swelling and 473 
histological lesions in the liver, spleen, gut and gill filaments. Regarding survival, this study 474 
demonstrated that once fish were exposed to the bacterial challenge they succeed in eliminating 475 
the pathogen from their bodies. The immune mechanisms by which the host may have 476 
eliminated the pathogen are likely related to innate immune effectors (Uribe et al., 2011; Whyte, 477 
2007), though this was outside the scope of this current work. 478 
Although our results suggest that horizontal transfer between carrier and healthy animals 479 
seemed not to occur for strain IRTA-17-43, it is important to note that gilthead seabream that 480 
are asymptomatic carriers of V. harveyi may act as a reservoir of the pathogen that could lead 481 
to outbreaks when optimal conditions occur. More importantly from a risk analysis perspective, 482 
is susceptible fish species, like European seabass, which might be reared in the same farm and/or 483 
area, as is characteristic of the Mediterranean aquaculture, face an elevated risk from pathogen 484 
transmission due to their higher vulnerability to this bacteria, as demonstrated (Pujalte et al., 485 
2003b). In the present study, no co-habitation trials were successful between both species, 486 
supporting previous studies. Although transmission between seabream and seabass did not 487 
occur using the dosage of 107 CFU mL-1, other dosages or different strains of V. harveyi may 488 
provide different results between the two host species.  489 
In conclusion, the results of the present study were in agreement with previous data on gilthead 490 
seabream as a source of V. harveyi, as well as the virulence of this bacterium for European 491 
seabass. It was demonstrated that signs of carrier-status of V. harveyi might be difficult to 492 
identify since infected individuals present few external signs, although internal effects of the 493 
infection were clear and severe. Despite the fact that in the current study no direct transmission 494 
of the pathogen was observed between infected and healthy fish within the same species, it is 495 
not guaranteed that infection could not cross between carriers and immunosuppressed 496 
individuals, or between different species. Therefore, the importance of a good health 497 
management system within fish farms cannot be overstated in order to avoid the onset of 498 
disease outbreaks and emergence of new pathogens due to the intensification of production 499 
systems, antibiotic resistance and climate change. This is of special relevance for V. harveyi 500 
infections, and Vibrio species more generally, as their prevalence is expected to increase due to 501 
climate change (Baker-Austin et al., 2013). In this sense, this study contributes with updated 502 
information that can be applied to the essential risk analysis of the aquaculture sector, which 503 
can be further improved. 504 
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